Literature DB >> 23213127

Severe obstructive sleep apnoea due to adenotonsillar hypertrophy after liver transplantation.

Omar Mulla1, Yogesh Bajaj, Lindsey Knight.   

Abstract

Epstein-Barr virus-related adenotonsillar hypertrophy is a precursor to post-transplantation lymphoproliferative disorder. We report a case of a 4-year-old child with severe obstructive sleep apnoea, who had liver transplantation at the age of 7 months. She had gross lymphoid hypertrophy in the oropharynx and supraglottis. We performed an adenotonsillectomy and aryepiglottoplasty which improved her symptoms. We emphasise the importance to consider the diagnosis of post-transplantation lymphoproliferative disorder in post-transplantation immunosuppressed patients who present with adenotonsillar hypertrophy.

Entities:  

Mesh:

Year:  2012        PMID: 23213127      PMCID: PMC4544683          DOI: 10.1136/bcr-2012-007059

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  15 in total

1.  Epstein-Barr virus infection in paediatric liver transplant recipients: detection of the virus in post-transplant tonsillectomy specimens.

Authors:  N Meru; S Davison; L Whitehead; A Jung; D Mutimer; N Rooney; D Kelly; G Niedobitek
Journal:  Mol Pathol       Date:  2001-08

2.  Risk factors for adenotonsillar hypertrophy in children following solid organ transplantation.

Authors:  Nina L Shapiro; Ali M Strocker; Neil Bhattacharyya
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2003-02       Impact factor: 1.675

3.  Adenotonsillar hypertrophy and Epstein-Barr virus in pediatric organ transplant recipients.

Authors:  N L Shapiro; A M Strocker
Journal:  Laryngoscope       Date:  2001-06       Impact factor: 3.325

Review 4.  Risk factors and pathogenesis of posttransplant lymphoproliferative disorders.

Authors:  M Ho
Journal:  Transplant Proc       Date:  1995-10       Impact factor: 1.066

5.  Association between Epstein-Barr virus seroconversion and immunohistochemical changes in tonsils of pediatric solid organ transplant recipients.

Authors:  Nina L Shapiro; Christopher Guan-Zhong Tang; Neil Bhattacharyya
Journal:  Laryngoscope       Date:  2011-08       Impact factor: 3.325

6.  The effectiveness of tonsillectomy in diagnosing lymphoproliferative disease in pediatric patients after liver transplantation.

Authors:  S Broughton; J E McClay; A Murray; C Timmons; J Sommerauer; W Andrews; P Harkins
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2000-12

7.  Early signs and risk factors for the increased incidence of Epstein-Barr virus-related posttransplant lymphoproliferative diseases in pediatric liver transplant recipients treated with tacrolimus.

Authors:  E M Sokal; H Antunes; C Beguin; M Bodeus; P Wallemacq; J de Ville de Goyet; R Reding; M Janssen; J P Buts; J B Otte
Journal:  Transplantation       Date:  1997-11-27       Impact factor: 4.939

8.  Tonsil lymphoma presenting as tonsillitis after bone marrow transplantation.

Authors:  S A Yellin; M H Weiss; D H Kraus; E B Papadopoulos
Journal:  Otolaryngol Head Neck Surg       Date:  1995-04       Impact factor: 3.497

9.  Serial measurement of Epstein-Barr viral load in peripheral blood in pediatric liver transplant recipients during treatment for posttransplant lymphoproliferative disease.

Authors:  M Green; T V Cacciarelli; G V Mazariegos; L Sigurdsson; L Qu; D T Rowe; J Reyes
Journal:  Transplantation       Date:  1998-12-27       Impact factor: 4.939

10.  Prevention and preemptive therapy of postransplant lymphoproliferative disease in pediatric liver recipients.

Authors:  S V McDiarmid; S Jordan; G S Kim; M Toyoda; J A Goss; J H Vargas; M G Martín; R Bahar; A L Maxfield; M E Ament; R W Busuttil; G S Lee
Journal:  Transplantation       Date:  1998-12-27       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.